Searched for
ORAL ANTIBIOTIC
Shigella outbreak in Kerala: 10 new cases reported taking tally to 226; here's everything you need to know about the infectionKerala is grappling with a surge in Shigella infections, recording 226 cases this year and 150 in June alone, with six deaths reported. Out...- Shigella scare in Kerala: Check symptoms, treatment and causes of the infection that killed 4-year-old in KozhikodeShigella Spreading in Kerala? Kerala has intensified surveillance and testing following its first reported Shigella-related death of a four...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- After cough syrup tragedy, Madhya Pradesh hospital under lens over 'worms' in medicineA government hospital in Gwalior has sealed its entire stock of Azithromycin antibiotic after a complaint alleged worms were found in a bot...
- Common antibiotic may be cost-saving treatment for reducing maternal sepsis: StudyAdministering oral doses of the antibiotic azithromycin to pregnant individuals could potentially serve as a cost-effective measure for mit...
- Don't pop pills: High antibiotic use may increase risk of Parkinson'sConstipation and irritable bowel syndrome have also been associated with a higher risk of the disease.
- 'Superbugs' hinder kidney infection treatmentPyelonephritis is an infection of the kidney which starts as a urinary tract infection causes fever, back pain & vomiting.
- New class of antibiotics discoveredScientists have discovered a new class of antibiotics to fight deadly bacteria such as methicillin-resistant Staphylococcus aureus and othe...
- Dr Reddy's launches Amoxicillin tablets, capsules in US marketDr Reddy's today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension.
- Lupin gets USFDA nod for CefdinirPharmaceutical company Lupin has received US Food and Drug Administration (FDA) approval for its antibiotic drug Cefdinir for oral suspensi...
- Lupin set to widen its base in paediatric mktPharmaceutical firm Lupin on Thursday said it has received US Food and Drug Administration (USFDA) approval for Suprax Cefixime, an antibio...
- Aurobindo Pharma gets USFDA nod for generic drugsAurobindo Pharma Ltd has received two more approvals from USFDA taking up the count generic approvals for the company to 35.
Load More
